Optimization of Radioembolic Effect with Extended-shelf-life Yttrium-90 Microspheres: Results from a Pilot Study

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 12, 2009, Pages 1557-1563

  Lewandowski, Robert J ^a   Riaz, Ahsun ^a   Ryu, Robert K ^a   Mulcahy, Mary F ^a   Sato, Kent T ^a   Kulik, Laura M ^b   Gates, Vanessa L ^a   Baker, Talia ^c   Omary, Reed ^a   Salem, Riad ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; MICROSPHERE; YTTRIUM 90;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; ARTIFICIAL EMBOLISM; BILIRUBIN BLOOD LEVEL; BRACHYTHERAPY; CANCER RADIOTHERAPY; CATHETER; CLINICAL ARTICLE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DEVICE; DOSIMETRY; DUODENUM ULCER; EUROPE; FATIGUE; FEMALE; FEVER; FOLLOW UP; HALF LIFE TIME; HUMAN; INTERVENTIONAL RADIOLOGY; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; LIVER METASTASIS; MALE; MEDICAL SOCIETY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIOEMBOLIZATION; SIDE EFFECT; STOMACH ULCER; TREATMENT OUTCOME; VOMITING; WORLD HEALTH ORGANIZATION;

AGED; CARCINOMA, HEPATOCELLULAR; DRUG STABILITY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIOGRAPHY, INTERVENTIONAL; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 70450284438     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.08.021     Document Type: Article

References (20)

1. Therasphere yttrium-90 microspheres. [package insert] (2004), MDS Nordion, Kanata, Canada
2. SIR-Spheres yttrium-90 microspheres. [package insert] (2004), Sirtex Medical, Lane Cove, Australia
3. Sato K., Lewandowski R.J., Bui J.T., et al. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (Therasphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 29 (2006) 522-529
4. Murthy R., Xiong H., Nunez R., et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16 (2005) 937-945
5. Campbell A.M., Bailey I.H., and Burton M.A. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 45 (2000) 1023-1033
6. Salem R., Lewandowski R.J., Atassi B., et al. Treatment of unresectable hepatocellular carcinoma with use of 90y microspheres (therasphere): safety, tumor response, and survival. J Vasc Interv Radiol 16 (2005) 1627-1639
7. Lewandowski R.J., Sato K.T., Atassi B., et al. Radioembolization with (90)y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30 (2007) 571-592
8. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
9. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 (2001) 421-430
10. Riaz A., Kulik L., Lewandowski R.J., et al. Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 49 (2009) 1185-1193
11. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
12. Salem R., and Thurston K.G. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. III. Comprehensive literature review and future direction. J Vasc Interv Radiol 17 (2006) 1571-1593
13. Atassi B., Bangash A.K., Bahrani A., et al. Multimodality imaging following 90y radioembolization: a comprehensive review and pictorial essay. Radiographics 28 (2008) 81-99
14. Liu D.M., Salem R., Bui J.T., et al. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16 (2005) 911-935
15. Salem R., Lewandowski R., Roberts C., et al. Use of yttrium-90 glass microspheres (Therasphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15 (2004) 335-345
16. Goin J.E., Dancey J.E., Roberts C.A., Sickles C.J., Leung D.A., and Soulen M.C. Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: trans-catheter arterial chemo-embolization versus yttrium-90 glass microspheres. World J Nucl Med 3 (2004) 49-56
17. Kulik L.M., Carr B.I., Mulcahy M.F., et al. Safety and efficacy of (90)y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47 (2007) 71-81
18. Koukourakis M.I. Tumour angiogenesis and response to radiotherapy. Anticancer Res 21 (2001) 4285-4300
19. Das U. A radical approach to cancer. Med Sci Monit 8 (2002) RA79-RA92
20. Rhee T.K., Omary R.A., Gates V., et al. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Interv Radiol 16 (2005) 1085-1091